文献速递消化内镜消化道肿瘤与早癌

新型人工智能系统在结肠镜检查中显著提高腺瘤检出数量

Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial.
PubMed 文献 · Am J Gastroenterol · 2024-01-18

美国多中心前瞻性随机试验纳入1031例平均风险受试者,比较CAD-EYE辅助结肠镜(CAC)与常规结肠镜(CC)的每结肠镜腺瘤数(APC)。CAC组APC显著高于CC组(0.99±1.6 vs 0.85±1.5,P=0.02),且退镜时间无显著差异,支持AI辅助结肠镜提高检查质量。

要点

  • AI辅助结肠镜显著提高每结肠镜腺瘤数(APC 0.99 vs 0.85,P=0.02)。
  • AI组退镜时间未显著延长(11.28 vs 10.8分钟,P=0.11)。
  • 腺瘤检出率、进展期腺瘤等指标组间无显著差异。

核心结论

  • 新型AI检测系统可显著提高每结肠镜腺瘤数,且不增加退镜时间。

研究设计与样本

  • 美国多中心前瞻性随机试验,改良意向性分析纳入1031例45岁及以上平均风险受试者。
  • 受试者随机接受CAD-EYE辅助结肠镜(CAC,510例)或常规结肠镜(CC,523例)。

主要发现

  • CAC组APC为0.99±1.6,CC组为0.85±1.5,P=0.02,发生率比1.17(1.03-1.33,P=0.02)。
  • 退镜时间CAC组11.28±4.59分钟,CC组10.8±4.81分钟,P=0.11。
  • 腺瘤阳性预测值CAC组48.6%,CC组54%,95%CI -9.56%至-1.48%。
  • 腺瘤检出率CAC组46.9%,CC组42.8%,无显著差异。
  • 每结肠镜息肉数CAC组1.68±2.1,CC组1.33±1.8,发生率比1.27(1.15-1.4,P<0.01)。

关键数值与推荐

  • 主要结局为每结肠镜腺瘤数(APC)。
  • 腺瘤阳性预测值差异小于预设的10%阈值(48.6% vs 54%,95%CI -9.56%至-1.48%)。

临床怎么用

  • 支持使用AI辅助结肠镜以提高结肠镜检查质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Adenoma per colonoscopy (APC) has recently been proposed as a quality measure for colonoscopy. We evaluated the impact of a novel artificial intelligence (AI) system, compared with standard high-definition colonoscopy, for APC measurement. METHODS: This was a US-based, multicenter, prospective randomized trial examining a novel AI detection system (EW10-EC02) that enables a real-time colorectal polyp detection enabled with the colonoscope (CAD-EYE). Eligible average-risk subjects (45 years or older) undergoing screening or surveillance colonoscopy were randomized to undergo either CAD-EYE-assisted colonoscopy (CAC) or conventional colonoscopy (CC). Modified intention-to-treat analysis was performed for all patients who completed colonoscopy with the primary outcome of APC. Secondary outcomes included positive predictive value (total number of adenomas divided by total polyps removed) and adenoma detection rate. RESULTS: In modified intention-to-treat analysis, of 1,031 subjects (age: 59.1 ± 9.8 years; 49.9% male), 510 underwent CAC vs 523 underwent CC with no significant differences in age, gender, ethnicity, or colonoscopy indication between the 2 groups. CAC led to a significantly higher APC compared with CC: 0.99 ± 1.6 vs 0.85 ± 1.5, P = 0.02, incidence rate ratio 1.17 (1.03-1.33, P = 0.02) with no significant difference in the withdrawal time: 11.28 ± 4.59 minutes vs 10.8 ± 4.81 minutes; P = 0.11 between the 2 groups. Difference in positive predictive value of a polyp being an adenoma among CAC and CC was less than 10% threshold established: 48.6% vs 54%, 95% CI -9.56% to -1.48%. There were no significant differences in adenoma detection rate (46.9% vs 42.8%), advanced adenoma (6.5% vs 6.3%), sessile serrated lesion detection rate (12.9% vs 10.1%), and polyp detection rate (63.9% vs 59.3%) between the 2 groups. There was a higher polyp per colonoscopy with CAC compared with CC: 1.68 ± 2.1 vs 1.33 ± 1.8 (incidence rate ratio 1.27; 1.15-1.4; P < 0.01). DISCUSSION: Use of a novel AI detection system showed to a significantly higher number of adenomas per colonoscopy compared with conventional high-definition colonoscopy without any increase in colonoscopy withdrawal time, thus supporting the use of AI-assisted colonoscopy to improve colonoscopy quality ( ClinicalTrials.gov NCT04979962).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Desai M, Ausk K, Brannan D, et al. Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial. Am J Gastroenterol. 2024. PMID: 38235741. doi:10.14309/ajg.0000000000002664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。